canakinumab
Drug Details
- Generic Name
- canakinumab
- Brand Names
- Ilaris
- Application Number
- BLA125319
- Sponsor
- Novartis Pharmaceuticals Corporation
- NDC Codes
- 2
- Dosage Forms
- INJECTION, SOLUTION
- Routes
- SUBCUTANEOUS
- Active Ingredients
- CANAKINUMAB
Indications and Usage
Immune support suring times of: Seasonal colds and flu
Warnings
Stop use and ask doctor if symptoms persist more than 5 days or worsen. If pregnant or breast-feeding ask a health professional before use. Keep out of reach of children.